New Trade Agreement Boosts European Stocks, But Its Impact Remains Limited.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 15 2026
0mins
Should l Buy SUZ?
Source: Barron's
- U.S. and China Rivalry: The ongoing competition between the U.S. and China for economic and geopolitical dominance is a significant global issue.
- Perception of Europe: Europe is often viewed as the "global sick man" amidst this rivalry, suggesting a decline in its influence and power.
- Implications for Global Politics: The dynamics between the U.S. and China may overshadow Europe's role in international affairs.
- Need for European Resilience: There is a growing need for Europe to strengthen its position and respond effectively to the challenges posed by the U.S.-China competition.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SUZ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SUZ
About SUZ
Suzano SA, formerly Suzano Papel e Celulose SA is a Brazil-based forestry company. It is a developer of products made from eucalyptus forests and a vertically integrated producer of eucalyptus pulp and paper in Latin America. Its purpose is to manufacture, trade, import and export pulp, paper and other products. The Company’s product portfolio includes coated and uncoated printing and writing paper, paperboard, tissue paper, market pulp and fluff pulp. Suzano’s operations are divided into two segments: Pulp and Paper. The Pulp segment includes the production and commercialization of eucalyptus pulp for the foreign market, with the surplus destined for the domestic market, while the Paper segment covers the activities of production and sale of uncoated and coated paperboard and tissue. The Company has numerous subsidiaries, including Fibria Terminal de Celulose de Santos Spe SA, FuturaGene Biotechnology Shanghai Co Ltd and Suzano Pulp and Paper Europe SA.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Significant Impact on Business: Suzano executives report a notable effect on business in the Middle East.
- Focus on Regional Developments: The emphasis is on the implications of these changes for the local economy and market dynamics.
See More

Impact of Prolonged Conflict: Prolonged conflict is expected to lead to higher global prices for essential goods, particularly toilet paper and tissues.
Economic Consequences: The ongoing situation may disrupt supply chains, contributing to inflation and increased costs for consumers worldwide.
See More

Impact of War on Transportation: The ongoing war has led to an increase in transportation costs for Brazilian companies, particularly affecting logistics and supply chains.
Rising Chemical Costs: The conflict has also resulted in higher chemical costs, impacting various industries reliant on these materials for production.
See More
- Market Underperformance: The paper and forest products sector is down approximately 3% overall, indicating a weak performance in the current market environment, which may affect investor confidence.
- Stock Drag: Suzano's stock has declined by about 6.5%, making it the worst performer in the sector, reflecting potential operational challenges or weakening market demand for the company.
- Mativ Holdings Struggles: Mativ Holdings' stock is down approximately 4.7%, further exacerbating investor concerns about the future performance of the industry, which could lead to capital outflows.
- Uncertain Industry Outlook: With overall market sentiment low, the future growth potential of the paper and forest products sector is in question, potentially requiring stronger market signals to restore investor confidence.
See More
- Price Target Cut: Deutsche Bank lowered its price target for Kimberly-Clark from $110 to $109 while maintaining a Hold rating, citing widespread pressures in the consumer goods sector linked to Middle East conflicts, which could weaken demand and increase costs, thereby impacting stock performance.
- Poor Market Performance: Analysts noted that Kimberly-Clark and its peers underperformed in March due to cost inflation and the risk of consumers trading down to cheaper products, indicating a potential decline in market confidence that could affect future investment decisions.
- Antitrust Investigation Initiated: The UK's Competition and Markets Authority has opened a phase 1 investigation into a $3.4 billion joint venture between Kimberly-Clark and Suzano, with a decision expected by May 28, which may influence Kimberly-Clark's market strategy and business expansion plans.
- Investment Potential Assessment: While Kimberly-Clark is viewed as a potential investment, analysts suggest that certain AI stocks offer greater upside potential and lower downside risk, advising investors to carefully consider market dynamics when making investment choices.
See More

- Joint Venture Overview: Kimberly-Clark (KMB) and Suzano (SUZ) are proposing a $3.4 billion joint venture that combines KMB's international family care and professional tissue business with Suzano's manufacturing scale and operational expertise, expected to close in mid-2026.
- Equity Structure and Funding: Under the agreement, Suzano will own 51% and Kimberly-Clark 49%, with Suzano paying approximately $1.734 billion in cash at closing, which will strengthen the financial foundation of the joint venture.
- Product and Market Coverage: The joint venture will produce, market, and distribute tissue products such as toilet paper, paper towels, napkins, and facial tissues across more than 70 countries, employing around 9,000 people and operating 22 manufacturing facilities, significantly enhancing market competitiveness.
- Regulatory Review and Governance Structure: The UK's Competition and Markets Authority has confirmed an investigation into the joint venture, with a phase 1 decision expected by May 28, and the venture will be governed by a five-member board with three directors appointed by Suzano and two by Kimberly-Clark.
See More







